Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
AstraZeneca
Johnson and Johnson
Express Scripts
Merck

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Litigation Details for Lannett Company Inc. v. KV Pharmaceuticals (D. Del. 2008)

See Plans and Pricing

« Back to Dashboard

Lannett Company Inc. v. KV Pharmaceuticals (D. Del. 2008)

Docket   Start Trial Date Filed 2008-06-06
Court District Court, D. Delaware Date Terminated 2009-03-23
Cause 28:1338 Patent Infringement Assigned To Joseph James Farnan Jr.
Jury Demand Both Referred To
Parties COLLINS J. SEITZ, JR.; DRUGTECH CORPORATION; KV PHARMACEUTICALS; LANNETT COMPANY INC.; THER-RX CORPORATION
Patents 6,716,814; 9,132,138
Attorneys Anne Shea Gaza; Chad Michael Shandler; Charles A. Weiss; Elizabeth A. Gardner; Eric E. Reed; Frederick L. Cottrell , III; Howard J. Shire; Jeffrey S. Ginsberg; Laura D. Hatcher; Richard L. DeLucia; Sophia Siddiqui
Firms COMMODITY FUTURES TRADING COMMISSION, Three Lafayette Centre; DLA Piper LLP; Richards, Layton & Finger, PA; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Lannett Company Inc. v. KV Pharmaceuticals
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in Lannett Company Inc. v. KV Pharmaceuticals

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Lannett Company Inc. v. KV Pharmaceuticals (D. Del. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-10-03 136 collectively, the “KV Patents”) and United States Patent Nos. 5,516,925 and 6,716,814 (collectively, “KV …With respect to U.S. Patents 6,258,846 (“‘846 patent”) and 6,576,666 (“‘666 patent”). For the reasons stated…OS_/OS PageBOflzpage|D#ZBGg patent, the ‘666 patent, and the ‘609 patent) are “invalid and/or unenforceable…to the ‘846 and ‘666 patents is granted I. BACKGROUND This action involves patents relating to multivitarnins… to the KV Patents, and Count Three asserts inequitable conduct directed to the ‘609 Patent. Counts Four External link to document
2008-06-24 30 Redacted Document Is Pharmaceutical Physics?” Pharm. Tech., 23(9), 132-138 (1999). H.G. Brittain “Microscopy - The First…Japanese Patent abstract No. 1 1-244908, Japanese Patent abstract No. 06- 151727, and Japanese Patent abstract…U.S. Patent 6,253,346 and 6,576,666, including the references cited therein; (c) European Patent application…Page 8 of 19 VI. U.S. Patent No. 6,576,666 A. The specification of` the ’666-patent According to the specification…Claims 1, 21 and 2_2_01` the ’666 patent Claim 1 of the ’666 patent recites the following composition External link to document
2008-06-10 4 Amended Complaint the ‘925 patent”), and U.S. Patent No. 6,716,814 (“the ‘814 patent”) are not infringed and/or invalid.… States Patent Filed 06/10/2008 Page 2 of 7 (12) (10) Patent No.: US 6,716,814 BZ Ericson…Document 4-8 Filed 06/10/2008 Page 3 of 7 US 6,716,814 B2 1 ENHANCING SOLUBILITY OF lRON AMINO ACID…Document 4-8 Filed 06/10/2008 Page 4 of 7 US 6,716,814 B2 3 l’ublishers, Springfield, Ill.; Ashmead…Document 4-8 Filed 06/10/2008 Page 5 of 7 US 6,716,814 B2 5 However, at the o.-amino group, the bond External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Boehringer Ingelheim
AstraZeneca
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.